Suppr超能文献

在一个西西里病例系列中进行 NGS 研究,该病例有 Gerstmann-Sträussler-Scheinker 综合征(PRNP,p.P102L)的基因诊断。

NGS study in a sicilian case series with a genetic diagnosis for Gerstmann-Sträussler-Scheinker syndrome (PRNP, p.P102L).

机构信息

Oasi Research Institute-IRCCS, Troina, EN, Italy.

U.O.S. Medical Genetics, Maria Paternò Arezzo Hospital, Ragusa, RG, Italy.

出版信息

Mol Biol Rep. 2023 Nov;50(11):9715-9720. doi: 10.1007/s11033-023-08764-z. Epub 2023 Oct 9.

Abstract

BACKGROUND

Gerstmann Sträussler Scheinker (GSS) is an inherited, invariably fatal prion disease. Like other human prion diseases, GSS is caused by missense mutations in the prion protein (PrP) gene (PRNP), and by the formation and overtime accumulation of the misfolded, pathogenic scrapie PrP (PrPSc). The first mutation identified in the PRNP gene, and the one blamed as the main cause of the disease, is c.C305T:p.P102L.

METHODS AND RESULTS

The Sanger sequencing method was performed on the PRNP gene for the detection of c.C305T:p.P102L mutations in a cohort of 10 subjects; moreover, a study was carried out, using Next Generation Sequencing (NGS), by sequencing a group of genes related to amyotrophic lateral sclerosis (ALS), Alzheimer's disease (AD), movement disorders and dementia which show a phenotypic profile similar to that of GSS. The results obtained from the study using NGS indicate the potential role of other genetic variants which could contribute to the various GSS phenotypes.

CONCLUSIONS

In conclusion, we highlight the large clinical variability in subjects presenting with GSS and p.P102L, as well as the hypothesis that the mutation in PrP codon 102 alone is not sufficient to trigger the cardinal clinical signs of the disease; furthermore, we do not exclude the possibility that further genetic variants play a decisive role in the aspects of the various phenotypes with which GSS manifests itself.

摘要

背景

Gerstmann-Straussler-Scheinker(GSS)是一种遗传性、不可避免的致命朊病毒病。与其他人类朊病毒病一样,GSS 是由朊蛋白(PrP)基因(PRNP)中的错义突变引起的,并且是由错误折叠的、致病的瘙痒 PrP(PrPSc)的形成和随着时间的推移积累引起的。在 PRNP 基因中鉴定出的第一个突变,也是被指责为疾病主要原因的突变,是 c.C305T:p.P102L。

方法和结果

对 PRNP 基因进行 Sanger 测序,以检测 10 名受试者中 c.C305T:p.P102L 突变;此外,还进行了一项研究,使用下一代测序(NGS)对一组与肌萎缩侧索硬化症(ALS)、阿尔茨海默病(AD)、运动障碍和痴呆相关的基因进行测序,这些基因表现出与 GSS 相似的表型特征。使用 NGS 进行的研究结果表明,其他遗传变异可能具有潜在作用,这些变异可能有助于各种 GSS 表型。

结论

总之,我们强调了表现出 GSS 和 p.P102L 的受试者的临床变异性很大,并且假设 PrP 密码子 102 中的突变本身不足以引发疾病的主要临床特征;此外,我们不排除其他遗传变异在 GSS 表现出的各种表型方面起决定性作用的可能性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验